E. Nüesch

705 total citations
25 papers, 579 citations indexed

About

E. Nüesch is a scholar working on Molecular Biology, Pharmacology and Analytical Chemistry. According to data from OpenAlex, E. Nüesch has authored 25 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Analytical Chemistry. Recurrent topics in E. Nüesch's work include Analytical Methods in Pharmaceuticals (5 papers), Anesthesia and Sedative Agents (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). E. Nüesch is often cited by papers focused on Analytical Methods in Pharmaceuticals (5 papers), Anesthesia and Sedative Agents (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). E. Nüesch collaborates with scholars based in Japan, Switzerland and Austria. E. Nüesch's co-authors include J. Rosenthaler, Klaus Kutz, B. von Graffenried, Klaus Abt, René Spiegel, L. Kerp, T. Beveridge, Kathrin Schlüter, Rolf Adler and E. del Pozo and has published in prestigious journals such as The Lancet, Pain and Clinical Pharmacology & Therapeutics.

In The Last Decade

E. Nüesch

24 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Nüesch Japan 13 132 130 111 93 74 25 579
R Dzúrik Slovakia 15 59 0.4× 157 1.2× 86 0.8× 157 1.7× 56 0.8× 113 828
R. M. H. Kater Australia 10 133 1.0× 79 0.6× 51 0.5× 57 0.6× 43 0.6× 16 617
Fabio Nelson Zuluaga Tobón United States 10 104 0.8× 58 0.4× 270 2.4× 53 0.6× 39 0.5× 21 745
Jane L.H.C. Third United States 14 95 0.7× 245 1.9× 258 2.3× 81 0.9× 33 0.4× 25 766
Roderick K. Roberts United States 10 75 0.6× 46 0.4× 198 1.8× 61 0.7× 103 1.4× 14 671
Yaohua Wu China 14 123 0.9× 114 0.9× 87 0.8× 227 2.4× 33 0.4× 36 741
A. R. Davidson United Kingdom 10 131 1.0× 26 0.2× 67 0.6× 83 0.9× 36 0.5× 16 604
James Speirs United States 14 40 0.3× 230 1.8× 349 3.1× 115 1.2× 49 0.7× 22 779
Victor Skrinska United States 16 56 0.4× 66 0.5× 85 0.8× 110 1.2× 97 1.3× 32 547
W S Hillis United Kingdom 19 73 0.6× 50 0.4× 195 1.8× 107 1.2× 43 0.6× 55 971

Countries citing papers authored by E. Nüesch

Since Specialization
Citations

This map shows the geographic impact of E. Nüesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Nüesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Nüesch more than expected).

Fields of papers citing papers by E. Nüesch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Nüesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Nüesch. The network helps show where E. Nüesch may publish in the future.

Co-authorship network of co-authors of E. Nüesch

This figure shows the co-authorship network connecting the top 25 collaborators of E. Nüesch. A scholar is included among the top collaborators of E. Nüesch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Nüesch. E. Nüesch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holmes, David, et al.. (1991). Steady state pharmacokinetics of hydrolysed bopindolol in young and elderly men. European Journal of Clinical Pharmacology. 41(2). 175–8. 1 indexed citations
2.
Fertil, Bernard, et al.. (1991). Exploratory analysis of population pharmacokinetic data from clinical trials with application to isradipine. Clinical Pharmacology & Therapeutics. 50(1). 39–54. 15 indexed citations
3.
Nüesch, E.. (1990). Extension of the loo-riegelman method to pharmacokinetic data at steady state. European Journal of Clinical Pharmacology. 39(1). 55–57.
4.
Zehnder, C, et al.. (1988). Cyclosporine A capsules: bioavailability and clinical acceptance study in renal transplant patients.. PubMed. 20(2 Suppl 2). 641–3. 12 indexed citations
5.
Rüegg, P. & E. Nüesch. (1987). The effect of a new inotropic agent, DPI 201‐106, on systolic time intervals and the electrocardiogram in healthy subjects.. British Journal of Clinical Pharmacology. 24(4). 453–458. 16 indexed citations
6.
Pozo, E. del, Michel Neufeld, Kathrin Schlüter, et al.. (1986). Endocrine profile of a long-acting somatostatin derivative SMS 201–995. Study in normal volunteers following subcutaneous administration. European Journal of Endocrinology. 111(4). 433–439. 102 indexed citations
7.
Pozo, E. del, Kathrin Schlüter, E. Nüesch, J. Rosenthaler, & L. Kerp. (1986). Pharmacokinetics of a long-acting bromocriptine preparation (Parlodel LA) and its effect on release of prolactin and growth hormone. European Journal of Clinical Pharmacology. 29(5). 615–618. 15 indexed citations
8.
Kutz, Klaus, E. Nüesch, & J. Rosenthaler. (1986). Pharmacokinetics of SMS 201-995 in Healthy Subjects. Scandinavian Journal of Gastroenterology. 21(sup119). 65–72. 126 indexed citations
9.
Shand, David G., Michael R. Hall, Stephen H. Buck, et al.. (1982). Opening Remarks by Prof. M. Bergener, Köln. Gerontology. 28(1). 1–4. 3 indexed citations
10.
Hitzenberger, G, et al.. (1982). Influence of Smoking and Age on Pharmacokinetics of β-Receptor Blockers. Gerontology. 28(1). 93–100. 6 indexed citations
11.
Graffenried, B. von, et al.. (1980). Assessment of analgesics in dental surgery outpatients. European Journal of Clinical Pharmacology. 18(6). 479–482. 19 indexed citations
12.
Herrmann, Ulrich, et al.. (1980). Analgesie effect of fluproquazone in postoperative patients. Clinical Pharmacology & Therapeutics. 27(3). 379–385. 5 indexed citations
13.
Graffenried, B. von & E. Nüesch. (1980). Non‐migrainous headache for the evaluation of oral analgesics.. British Journal of Clinical Pharmacology. 10(S2). 225S–231S. 20 indexed citations
14.
Vožeh, S., et al.. (1979). Absolute bioavailability of digoxin in chronic renal failure.. PubMed. 11(6). 302–6. 11 indexed citations
15.
Graffenried, B. von, Rolf Adler, Klaus Abt, E. Nüesch, & René Spiegel. (1977). The influence of anxiety and pain sensitivity on experimental pain in man. Pain. 4(Supp C). 253–263. 60 indexed citations
16.
Meier, J. & E. Nüesch. (1977). Pindolol, a beta‐adrenoceptor blocking agent with a negligible first‐ pass effect.. British Journal of Clinical Pharmacology. 4(3). 371–372. 19 indexed citations
17.
Nüesch, E., et al.. (1977). Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man.. PubMed. 15(3). 106–12. 70 indexed citations
18.
Beveridge, T., et al.. (1976). Pharmacokinetic study with synthetic salmon calcitonin (Sandoz).. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 12–5. 14 indexed citations
19.
Vožeh, S., et al.. (1975). [Proceedings: Studies on the digoxin resorption in patients with decompensated right cardiac insufficiency].. PubMed. 105(51). 1782–3. 4 indexed citations
20.
Beveridge, T., et al.. (1973). BIOAVAILABILITY OF DIGOXIN. The Lancet. 302(7827). 499–499. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026